E.‐B. Bröcker

Final results of the EORTC 18871/DKG 80-1 randomised phase III trial

Ulrich R. Kleeberg, Stefan Suciu, E.‐B. Bröcker et al. · European Journal of Cancer · 2003 · 240 citations

Public Health, Internal Medicine, Experimental Design +8

A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes.

G. Zwadlo, E.‐B. Bröcker, D. B. v. Bassewitz et al. · The Journal of Immunology · 1985 · 236 citations

Life Sciences, Immunology, Pathology +16

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

Hywel C Williams, Fenella Wojnarowska, Gudula Kirtschig et al. · The Lancet · 2017 · 216 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Emergence of α5β1 fibronectin‐ and αvβ3 vitronectin‐receptor expression in melanocytic tumour progression

Erik H.J. Danen, P. J. M. ten Berge, Goos N.P. van Muijen et al. · Histopathology · 1994 · 122 citations

Medicine, Molecular Biology, Oncology +14

Differential Expression of Chemokines in Patients with Localized and Diffuse Cutaneous American Leishmaniasis

Uwe Ritter, Heidrun Moll, Tamás Laskay et al. · The Journal of Infectious Diseases · 1996 · 119 citations · Full text

Life Sciences, Immunology, Pathology +17